摘要
青光眼滤过术是目前抗青光眼药物及激光治疗无法控制眼压时的首选手术方式,其术后滤过泡瘢痕形成是导致手术失败的重要原因。目前在抗青光眼术后瘢痕的基础及临床研究上有一定的进展,但寻求一种高效、安全、稳定的药物治疗青光眼滤过术后瘢痕形成仍是一个需要继续努力解决的问题。本文就近3a所发表的关于青光眼滤过术后抗瘢痕形成的相关药物研究作一综述。
Glaucoma filtration surgery is currently the preferred method for patients in whom anti-glaucoma medication and laser treatment can not control intraocular pressure, and its postoperative filtering bleb scar formation is the leading cause of surgical failure. At present, there are some progresses in the basic and clinical studies of postoperative anti-glaucoma scar. However, it is still a problem to seek for an effective, safe and stable treatment of scarring after glaucoma filtration surgery. Those articles published in the past three years on the glaucoma filtration after anti-scarring related drugs are reviewed.
作者
黄智华
谭薇
Zhi-Hua Huang;Wei Tan(Department of Ophthalmology,the Third Affiliated Hospital of ZunyiMedical Universit;Zunyi Eye Clinic Medical Center,Zunyi563000,Guizhou Province,China)
出处
《国际眼科杂志》
CAS
北大核心
2018年第7期1228-1232,共5页
International Eye Science
基金
贵州省自然科学基金资助项目[No.黔省专合字(2012)131号]
遵义市创新人才团队基金资助项目[No.遵市科合(2015)43号]
关键词
青光眼
滤过手术
抗瘢痕药物
glaucoma
filtration surgery
anti-scarring drugs
